<DOC>
	<DOCNO>NCT00829738</DOCNO>
	<brief_summary>The aim study evaluate effect 14 day treatment Pantoprazole 40 mg 20 mg gastroesophageal reflux disease ( GERD ) relate symptom large patient population .</brief_summary>
	<brief_title>Efficacy Pantoprazole 20/40 mg Once Daily ( od ) Patients Older Than 12 Years Who Have Gastrointestinal Symptoms Reflux Disease</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Main inclusion criterion : Outpatients gastroesophageal reflux disease ( GERD ) Main exclusion criterion : Criteria define Summary Product Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>PPI therapy</keyword>
	<keyword>pantoprazole</keyword>
	<keyword>GERD ( Erosive Gastroesophageal Reflux Disease )</keyword>
</DOC>